News about "pharma deal"

Zydus and Torrent Pharma Sign Licensing Deal to Co-Market Semaglutide in India

Zydus Lifesciences and Torrent Pharmaceuticals have entered a licensing agreement to co-market Semaglutide injection in India, aiming to improve access for patients with poorly controlled Type 2 Diabetes Mellitus and support chronic weight management through advanced, innovative therapy.

Pharma Deal | 19/03/2026 | By News Bureau |  167

Innovent Collaborates with Lilly to Develop New Medicines in Oncology and Immunology

The agreement grants Lilly an exclusive licence to develop and commercialise the programmes worldwide outside Greater China, while Innovent retains rights in Greater China.

Pharma Deal | 09/02/2026 | By News Bureau

AstraZeneca Boosts Weight Management Portfolio via CSPC Collaboration

Under this agreement, Astrazeneca and CSPC Pharmaceuticals will initially progress four programmes, which utilise CSPC's advanced Artificial Intelligence (AI)-driven peptide drug discovery platform and their proprietary LiquidGel once-monthly dosing platform technology.

Pharma Deal | 31/01/2026 | By News Bureau |  240

Concerto and Sacco System Sign Microbial Discovery Deal

Concerto and Sacco System aim to develop novel ingredients composed of synergistically interacting microbes with desirable functional properties.

Pharma Deal | 30/01/2026 | By News Bureau

Boehringer and Simcere Partner on Dual-Target IBD Antibody

Boehringer Ingelheim has signed a licence and collaboration deal with Simcere to develop a novel TL1A/IL23p19 bispecific antibody for inflammatory bowel disease, gaining global rights outside greater China, with Simcere eligible for up to €1.058 billion in payments.

Pharma Deal | 29/01/2026 | By News Bureau |  110

Worldwide Clinical Trials to Acquire Catalyst Clinical Research

Worldwide Clinical Trials has entered into a definitive agreement to acquire Catalyst Clinical Research, a move aimed at expanding its functional service provider capabilities, strengthening its global site network, boosting oncology expertise, and accelerating technology integration to enhance efficiency and transparency for customers.

Pharma Deal | 21/01/2026 | By News Bureau |  280

Serum Institute to Produce 100,000 Doses of Oxford Rift Valley Fever Vaccine

Serum Institute of India will produce up to 100,000 doses of an investigational Rift Valley fever vaccine developed by the University of Oxford, as the viral disease continues to affect parts of West Africa. The doses may be used for testing and future outbreak response, under an agreement supported by CEPI.

Pharma Deal | 17/01/2026 | By News Bureau |  119

Biocon Raises INR 4,150 Crore via QIP

Biocon has successfully raised INR 4,150 crore through a Qualified Institutions Placement (QIP), with the proceeds set to be primarily used to fund the cash consideration payable to Mylan Inc. (Viatris) for the buyout of its stake in Biocon Biologics, including the repayment of related acquisition debt.

Pharma Deal | 15/01/2026 | By News Bureau |  130

Bayer to Enter Molecular Imaging, Acquires Pan-Amyloid Radiotracers from Attralus

By acquiring AT-01 and AT-05 from Attralus, Bayer strengthens its molecular imaging and cardiovascular precision medicine portfolio, targeting earlier and more accurate diagnosis of amyloidosis.

Pharma Deal | 14/01/2026 | By News Bureau |  209

Esco Aster Signs cGMP Exosome Manufacturing Deal with Shine-On Biomedical

Esco Aster has entered into a clinical cGMP manufacturing agreement with Shine-On Biomedical to support the production of a first-in-class HLA-G–targeting exosome drug delivery platform, while also providing technical services for exploratory exosome loading feasibility studies to advance the programme’s development.

Pharma Deal | 07/01/2026 | By News Bureau |  125